John Dahldorf Joins Benvenue Medical as Chief Financial Officer
March 23, 2015John Dahldorf joins Benvenue Medical as chief financial officer. In this role Dahldorf, who brings more than 30 years of financial, operational and leadership experience in the industry, will help shape the company’s long-term strategy and ensure capital
More »
Study Points Way to New Treatment Procedure for Acne
March 20, 2015Sebacia's clinical research in the #1 dermatology journal showed a procedure using a new topical with gold microparticles and an approved hair removal laser could selectively target and reduce the activity of sebaceous glands, which are responsible for ac
More »
Esperion Therapeutics Announces Positive Top-Line Phase 2b Results for ETC-1002 Added to Stable Statin Therapy in Patients With Hypercholesterolemia
March 17, 2015Esperion Therapeutics announces positive top-line results from its Phase 2b study evaluating the efficacy and safety of ETC-1002 in lowering LDL-cholesterol in patients with hypercholesterolemia on stable statin therapy.
More »